Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis

Volume: 4, Issue: 5, Pages: 880 - 884
Published: Mar 4, 2020
Abstract
Despite achieving a hematologic complete response after treatment, many patients with AL amyloidosis do not attain recovery of organ function and/or experience hematologic relapse. A persistent plasma cell clone producing amyloidogenic light chains at levels below the detection threshold of traditional serologic methods is hypothesized to impede organ response in some patients. Assessment of minimal residual disease (MRD) may therefore have...
Paper Details
Title
Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis
Published Date
Mar 4, 2020
Volume
4
Issue
5
Pages
880 - 884
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.